For story suggestions or custom animation requests, contact tips@nextanimation.com.tw. Visit [ Ссылка ] to view News Direct's complete archive of 3D news animations.
RESTRICTIONS: Broadcast: NO USE JAPAN, NO USE TAIWAN Digital: NO USE JAPAN, NO USE TAIWAN
Taking a daily low-dose aspirin may have no benefit, or might actually be harmful to healthy, older adults, according to a new study.
The study followed more than 19,000 people ages 65 and older in the United States and Australia for an average of 4.7 years, according to NPR. The results were published in the New England Journal of Medicine on Sunday.
Participants were given 100 milligrams of aspirin daily or a placebo.
According to NBC News, at the end of the trial period, 90.3 percent of the aspirin-treated patients were still alive, compared with 90.5 percent of those given placebos.
The rates of physical disability and dementia were similar in both groups, while the rates of coronary heart disease, heart attacks and strokes were also similar.
"We found there was no discernible benefit of aspirin on prolonging independent, healthy life for the elderly," said Anne Murray, a geriatrician and epidemiologist at Hennepin Healthcare in Minneapolis, who helped lead the study, according to NPR.
The study found a significant risk of internal gastric bleeding in the aspirin-treated group, as well as a slight increase in cancer deaths within the same group.
RUNDOWN SHOWS:
1. Aspirin pills may have no benefit or might be harmful to older, healthy adults
2. Study followed 19,000 participants for an average of 4.7 years
3. Results for the aspirin-treated group and placebo-treated group were similar
4. Aspirin group had internal gastric bleeding and increase in cancer deaths
VOICEOVER (in English):
"According to a new study published in the New England Journal of Medicine, taking a daily low-dose aspirin may have no benefit, or might actually be harmful to healthy, older adults."
"According to NPR, the study followed more than 19,000 people ages 65 and older in the United States and Australia for an average of 4.7 years. Participants were given 100 milligrams of aspirin daily or a placebo."
"According to NBC News, at the end of the trial, 90.3 percent of the aspirin-treated patients were still alive, compared with 90.5 percent of those given placebos. The rates of physical disability and dementia were similar in both groups, while the rates of coronary heart disease, heart attacks and strokes were also similar."
"The study found a significant risk of internal gastric bleeding in the aspirin-treated group, as well as a slight increase in cancer deaths with the aspirin group."
SOURCES: NPR, NBC News
[ Ссылка ]
[ Ссылка ]
***
------------------------------------------------------------------------------------------------
Next Animation Studio’s News Direct service provides daily, high-quality, informative 3D news animations that fill in for missing footage and help viewers understand breaking news stories or in-depth features on science, technology, and health.
Sign up for a free trial of News Direct's news animations at [ Ссылка ]
To subscribe to News Direct or for more info, please visit:
[ Ссылка ]
